Yilmaz G, Eyigor H, Gur O E, Kalkan T, Gur N, Selcuk O T, Ozturk Yilmaz G, Cetinkaya E A
Otorhinolaryngology, Antalya Training and Research Hospital, Antalya, Turkey.
Medical Genetics, Antalya Training and Research Hospital, Antalya, Turkey.
Rhinology. 2023 Feb 1;61(1):54-60. doi: 10.4193/Rhin22.118.
Recent studies reported the relationship between genetic variations and TAS2R38, which is a bitter taste receptor expressed in the cilia of human sinonasal epithelial cells, among the predisposing factors playing role in immune response to upper respiratory tract bacterial infection. The present study aims to examine the relationship of TAS2R38 genotype with the active microorganism and the effect of genotype on the surgical outcomes among chronic rhinosinusitis patients.
34 patients undergoing endoscopic sinus surgery (ESS) for chronic rhinosinusitis with or without polyps (23 CRSwNP, 11 CRSsNP) and 30 patients undergoing septoplasty surgery for isolated nasal septum deviation were included. All the patients were genotyped for TAS2R38. Scoring was made using endoscopic Modified Lund-Kennedy and radiological Lund-Mackay systems preoperatively. Sino-Nasal Outcome Test with 22 items (SNOT-22) was implemented preoperatively and postoperatively. Nasal swab culture samples were taken intraoperatively from CRS patients and the active microorganism were isolated.
In the TAS2R38 genotyping of the study group, PAV/PAV was found in 32.4% of patients, PAV/AVI in 47.1%, and AVI/AVI in 20.6%. In the control group, PAV/PAV was found in 26.7%, PAV/AVI in 36.7%, and AVI/AVI in 36.7%. In the study group, there was no statistically significant difference between the CRS and CRS subgroups in terms of TAS2R38 genotype distributions. The changes in patients' preoperative and postoperative SNOT-22 scores were similar between the genotypes. Proliferation was detected in culture in the whole AVI-AVI group, 81.8% of PAV-PAV group, and 56.3% of PAV-AVI group but the difference was not found to be statistically significant. The proliferation level of Staphylococcus epidermidis by TAS2R38 genotype was found to be statistically significantly higher among patients, who had AVI-AVI genotype, in CRSwNP.
We did not find a statistically significant relationship between the TAS2R38 genotype and CRS subtype, sinonasal bacterial infection risk increase and surgical success rate in CRS patients. Long-term and large-scale studies are needed, which are to be carried out by individual genotyping and sequencing to provide more information on the effects of these genetic variants.
最近的研究报道了基因变异与TAS2R38之间的关系,TAS2R38是一种在人鼻窦上皮细胞纤毛中表达的苦味受体,在上呼吸道细菌感染的免疫反应中起作用的易感因素中。本研究旨在探讨慢性鼻窦炎患者中TAS2R38基因型与活性微生物的关系以及基因型对手术效果的影响。
纳入34例因慢性鼻窦炎伴或不伴息肉接受鼻内镜鼻窦手术(ESS)的患者(23例慢性鼻窦炎伴鼻息肉,11例慢性鼻窦炎不伴鼻息肉)和30例因单纯鼻中隔偏曲接受鼻中隔成形术的患者。所有患者均进行TAS2R38基因分型。术前使用内镜改良Lund-Kennedy评分系统和放射学Lund-Mackay评分系统进行评分。术前和术后实施22项鼻鼻窦结局测试(SNOT-22)。术中从慢性鼻窦炎患者中采集鼻拭子培养样本并分离活性微生物。
在研究组的TAS2R38基因分型中,32.4%的患者为PAV/PAV,47.1%为PAV/AVI,20.6%为AVI/AVI。在对照组中,PAV/PAV为26.7%,PAV/AVI为36.7%,AVI/AVI为36.7%。在研究组中,慢性鼻窦炎组和慢性鼻窦炎亚组在TAS2R38基因型分布方面无统计学显著差异。各基因型患者术前和术后SNOT-22评分的变化相似。在整个AVI-AVI组、81.8%的PAV-PAV组和56.3%的PAV-AVI组的培养物中检测到增殖,但差异无统计学意义。在慢性鼻窦炎伴鼻息肉患者中,发现AVI-AVI基因型患者中表皮葡萄球菌的增殖水平在统计学上显著更高。
我们未发现CRS患者中TAS2R38基因型与CRS亚型、鼻窦细菌感染风险增加及手术成功率之间存在统计学显著关系。需要进行长期和大规模研究,通过个体基因分型和测序来提供更多关于这些基因变异影响的信息。